@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@o
30344
ŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞ
@@@Ęí[hÉßé@@Ť@@hmcdw@@Ť@@áOÖ@@ @@Öâ@@@
ŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞ
@ĽK
y {uz
tp Franbvksow 21/1/6(
) 14:50
@
@Ąčź F K
y {uz
tp
@ĄźO F Franbvksow <dermowe@hrunopot.com>
@Ąút F 21/1/6(
) 14:50
@Ąv
F https://onko-pharma.kz
@-------------------------------------------------------------------------
| B y~u~u-pu{u }w~ xp{pxp ~|pz~ @rpy~ (Avastin) ~uts p}z t
~z u~u r Kpxpp~u r {pxpp~u { y {pq|py~ { y r {pxpp~u {pq|py~ urp 150 |u~ry}p y~ {y y}u~u~y pp~ { y y}q ry{p u~p r q| [url=https://onko-pharma.kz]ofatumumab u~p[/url] [url=https://onko-pharma.kz]ruxolitinib u~p[/url] [url=https://onko-pharma.kz]{p|yrp u~p[/url] [url=https://onko-pharma.kz]~{up qurpx }pq {|{ y[/url] [url=https://onko-pharma.kz] u~ xr[/url] |